BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28661901)

  • 41. Metabolic disorders.
    Gregory JW
    Endocr Dev; 2009; 15():59-76. PubMed ID: 19293604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer.
    Gleeson HK; Darzy K; Shalet SM
    Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):335-48. PubMed ID: 12064896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocrine Sequelae in Childhood Cancer Survivors.
    George SA; Effinger KE; Meacham LR
    Endocrinol Metab Clin North Am; 2020 Dec; 49(4):565-587. PubMed ID: 33153668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endocrine Consequences of Childhood Cancer Therapy and Transition Considerations.
    Yu C
    Pediatr Ann; 2019 Aug; 48(8):e326-e332. PubMed ID: 31426101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The hypothalamic-pituitary-adrenal axis in childhood cancer survivors.
    Wei C; Crowne EC
    Endocr Relat Cancer; 2018 Oct; 25(10):R479-R496. PubMed ID: 29895525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DIAGNOSIS OF ENDOCRINE DISEASE: Endocrine late-effects of childhood cancer and its treatments.
    Chemaitilly W; Cohen LE
    Eur J Endocrinol; 2017 Apr; 176(4):R183-R203. PubMed ID: 28153840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endocrine late effects of cancer treatment.
    Cohen LE
    Curr Opin Pediatr; 2003 Feb; 15(1):3-9. PubMed ID: 12544265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.
    Tonorezos ES; Hudson MM; Edgar AB; Kremer LC; Sklar CA; Wallace WH; Oeffinger KC
    Lancet Diabetes Endocrinol; 2015 Jul; 3(7):545-55. PubMed ID: 25873569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease.
    Cooper OB; Brown TT; Dobs AS
    Clin Infect Dis; 2003; 37 Suppl 2():S132-6. PubMed ID: 12942387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Childhood Cancer Treatments and Associated Endocrine Late Effects: A Concise Guide for the Pediatric Endocrinologist.
    Chemaitilly W; Sklar CA
    Horm Res Paediatr; 2019; 91(2):74-82. PubMed ID: 30404091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late complications in childhood central nervous system tumour survivors.
    Anderson NE
    Curr Opin Neurol; 2003 Dec; 16(6):677-83. PubMed ID: 14624076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Late endocrine and growth sequelae after cancer treatment in children].
    Birkebaek NH; Helgestad JE
    Ugeskr Laeger; 1994 Aug; 156(32):4559-61, 4564-5. PubMed ID: 7832924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endocrine sequelae in childhood cancer survivors.
    Casano Sancho P
    Endocrinol Diabetes Nutr; 2017 Nov; 64(9):498-505. PubMed ID: 29050706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era.
    Phelan R; Eissa H; Becktell K; Bhatt N; Kudek M; Nuechterlein B; Pommert L; Tanaka R; Baker KS
    Curr Oncol Rep; 2019 Nov; 21(12):104. PubMed ID: 31768799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early and late endocrine effects in pediatric central nervous system diseases.
    Aslan IR; Cheung CC
    J Pediatr Rehabil Med; 2014; 7(4):281-94. PubMed ID: 25547881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endocrine side effects induced by immune checkpoint inhibitors.
    Corsello SM; Barnabei A; Marchetti P; De Vecchis L; Salvatori R; Torino F
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1361-75. PubMed ID: 23471977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Endocrine sequelae after radiotherapy in childhood and adolescence].
    Couto-Silva AC; Brauner R; Adan LF
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):825-32. PubMed ID: 16444367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of cancer treatment on hypothalamic-pituitary function.
    Crowne E; Gleeson H; Benghiat H; Sanghera P; Toogood A
    Lancet Diabetes Endocrinol; 2015 Jul; 3(7):568-76. PubMed ID: 25873572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endocrine and metabolic manifestations of invasive fungal infections and systemic antifungal treatment.
    Lionakis MS; Samonis G; Kontoyiannis DP
    Mayo Clin Proc; 2008 Sep; 83(9):1046-60. PubMed ID: 18775205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiation-induced hypopituitarism.
    Fernandez A; Brada M; Zabuliene L; Karavitaki N; Wass JA
    Endocr Relat Cancer; 2009 Sep; 16(3):733-72. PubMed ID: 19498038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.